United KingdomOver 150 deaths have been linked to the use of weight loss medications, specifically GLP-1 drugs like Saxenda, Wegovy, and Mounjaro, according to data from the Medicines and Healthcare Products Regulatory Agency (MHRA). Patients have submitted approximately 150,000 reports of adverse effects, with Mounjaro (tirzepatide) having the highest number of serious side-effect reports and fatalities. The MHRA's Yellow Card scheme collects these reports, noting that while many side effects are mild, such as digestive issues, there are concerns about more severe outcomes like heart problems, neurological disorders, and fatal gastrointestinal complications. The agency emphasized that while these reports are significant, they represent a small fraction of the millions of prescriptions issued in the UK, and fatalities may not always be directly caused by the medication.
Bias read (Center): The article presents factual data from the MHRA without overtly criticizing or praising any political entity, party, or ideology. While the topic involves health regulation and pharmaceutical oversight, which can have political implications, the framing remains neutral, focusing on medical data and藥
